Plunkett Research Online: Relmada Therapeutics Inc

RELMADA THERAPEUTICS INC (RLMD:PINX) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of proven drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The product portfolio of the company includ.....



Relmada Therapeutics Inc
Ticker: RLMD
Exchange: PINX
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone:
Fax:
Address: 750 Third Avenue
9th Floor
New York, NY 10017 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceuticals, Biopharmaceuticals, Generics and Drug Manufacturing
ContactsDescription
Sergio TraversaCEO/CFO/Chief Accounting Officer/Director
Charles CasamentoChairman of the Board/Director
See More
Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of proven drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The product portfolio of the company includ.....See More See More

Auditor: GBH CPAs, PC
Legal Advisor:
$USD, In whole numbers,
except marked * or %
201720162015201420132012
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: